Ubs Group Ag Zomedica Corp. Transaction History

Ubs Group Ag

$527 Billion
Q4 2024

A detailed history of Ubs Group Ag transactions in Zomedica Corp. stock. As of the latest transaction made, Ubs Group Ag holds 3,935,437 shares of ZOM stock, worth $472,252. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,935,437

Previous 44,528 8738.12%

Holding current value

$472,252

Previous $6,000 7766.67%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$0.12 - $0.15 $466,909 - $583,636	3,890,909 Added 8738.12%	3,935,437 $472,000
Q3 2024 Nov 14, 2024	SELL	$0.12 - $0.16 $3,352 - $4,470	-27,939 Reduced 38.55%	44,528 $6,000
Q2 2024 Aug 13, 2024	SELL	$0.12 - $0.18 $17,814 - $26,721	-148,455 Reduced 67.2%	72,467 $10,000
Q1 2024 May 13, 2024	BUY	$0.12 - $0.19 $26,510 - $41,975	220,922 New	220,922 $33,000
Q3 2023 Nov 09, 2023	BUY	$0.16 - $0.23 $2,497 - $3,589	15,608 Added 470.69%	18,924 $3,000
Q2 2023 Aug 11, 2023	SELL	$0.19 - $0.22 $3,240 - $3,752	-17,057 Reduced 83.72%	3,316 $0
Q1 2023 May 12, 2023	BUY	$0.16 - $0.29 $3,259 - $5,908	20,373 New	20,373 $4,000
Q3 2022 Nov 10, 2022	BUY	$0.2 - $0.38 $17,147 - $32,579	85,736 Added 68.61%	210,693 $44,000
Q2 2022 Aug 10, 2022	SELL	$0.2 - $0.34 $15,008 - $25,514	-75,043 Reduced 37.52%	124,957 $27,000
Q1 2022 May 16, 2022	BUY	$0.28 - $0.4 $37,795 - $53,993	134,984 Added 207.62%	200,000 $67,000
Q4 2021 Feb 14, 2022	BUY	$0.31 - $0.58 $559 - $1,046	1,805 Added 2.86%	65,016 $20,000
Q3 2021 Nov 15, 2021	SELL	$0.46 - $0.81 $162,481 - $286,108	-353,220 Reduced 84.82%	63,211 $33,000
Q2 2021 Aug 13, 2021	BUY	$0.72 - $1.46 $290,983 - $590,050	404,144 Added 3289.2%	416,431 $347,000
Q1 2021 May 12, 2021	BUY	$0.35 - $2.7 $1,257 - $9,698	3,592 Added 41.31%	12,287 $20,000
Q4 2020 Feb 11, 2021	BUY	$0.07 - $0.25 $608 - $2,173	8,695 New	8,695 $2,000

Others Institutions Holding ZOM

# of Institutions

Shares Held

91.7M

Call Options Held

Put Options Held

View Full List

About Zomedica Corp.

Ticker ZOM
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 979,950,016
Market Cap $118M
Description
Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA platform, which offers point-of-care diagnostic products for disease states in dogs and cats; and PulseVet, provides for treatment...

More about ZOM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account